AstraZeneca (LSE:AZN) Other Operating Expense : £-212 Mil (TTM As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Other Operating Expense?

AstraZeneca's Other Operating Expense for the three months ended in Mar. 2024 was £-53 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was £-212 Mil.

AstraZeneca's quarterly Other Operating Expense increased from Sep. 2023 (£-57 Mil) to Dec. 2023 (£518 Mil) but then declined from Dec. 2023 (£518 Mil) to Mar. 2024 (£-53 Mil).

AstraZeneca's annual Other Operating Expense declined from Dec. 2021 (£-156 Mil) to Dec. 2022 (£-245 Mil) and declined from Dec. 2022 (£-245 Mil) to Dec. 2023 (£-265 Mil).

AstraZeneca Other Operating Expense Historical Data

The historical data trend for AstraZeneca's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Other Operating Expense Chart

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

-243.40

-360.84

-155.66

-244.66

-265.44

AstraZeneca Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															-113.71	-620.93	-56.56	518.24	-52.73

AstraZeneca Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was £-212 Mil.

AstraZeneca Other Operating Expense Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (LSE:AZN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (LSE:AZN) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:USA AZN:Sweden AZNN:Mexico AZNl:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.